Quibim, a Spanish company based in Valencia, has become a reference in the field of medical technology. Specializing in the development of software based on artificial intelligence, its main objective is harness the potential of medical imaging to detect diseases more accurately and earliersomething that marks a before and after in the field of health. This advancement is particularly relevant in cancer detection, an area where AI is proving critical to improving clinical outcomes.
Products designed for early cancer detection
Among Quibim’s most innovative products are QP-Prostate and QP-Brain, both intended to detect and monitor diseases that pose a serious health risk.
QP-Prostate, for example, is designed to detect suspicious lesions in the prostate. Using AI, the software cross-references data from biopsies and MRIs, achieving greater precision than traditional analyses. This technology is already certified by the FDA in the United States, as well as by European and British authorities, allowing its clinical use on an international scale.
On the other hand, QP-Brain focuses on the detection of atrophies and brain lesions by magnetic resonance imaging, being an essential tool for the early diagnosis and monitoring of neurological diseases, such as Alzheimer’s disease.
Early detection of lung cancer and liver disease
Quibim has also developed QP-Liveran innovative solution for the diagnosis of liver diseases thanks to Accurate quantification of fat and iron in liver tissues. In this way, the platform allows doctors to detect liver conditions at an early stage, thereby significantly improving the chances of successful treatment.
Regarding lung cancer, one of the deadliest in the world, Quibim has launched algorithms that help identify lung lesions that might go unnoticed with traditional techniques. AI’s ability to cross-reference large volumes of data and detect patterns invisible to the human eye is proving to be a revolutionary advancement in the field of oncology.
Global implementation in hospitals and research centers
Quibim technology This is already a reality in more than 150 hospitals and research centers in Europe, the United States, Japan, South America and Australia. Collaboration with doctors and researchers has improved the knowledge and treatment of various serious diseases, providing patients with a real opportunity to improve their prognosis through early detection and personalization of treatments.
In Spain, several hospitals are already using these solutions, allowing healthcare professionals Work with more precision and speed. The use of advanced algorithms not only improves diagnostic capability but also optimizes workflows in hospitals, resulting in more effective and efficient care.
Confidentiality and data security at the heart of innovation
One of the biggest concerns with using AI in healthcare is data security. Quibim has met this challenge by implementing strict data protection policies. Your platform QP-Insights offers a secure infrastructure for storing and analyzing medical image dataguaranteeing patient confidentiality at all times. In addition, harmonization of data between different equipment and protocols is ensured, which reduces variability and increases diagnostic reliability.
Towards a new future
AI is transforming medicine and Quibim is at the forefront of this change. Its technology allows detect diseases earlier and more accurately, which considerably improves the chances of treatment success. With a strong foundation in research and extensive implementation in hospitals around the world, Quibim demonstrates that the future of healthcare lies in the intelligent use of AI.
